INTERPACE BIOSCIENCES®

Interpace Diagnostics®, LLC is a subsidiary of Interpace Biosciences and is a fully integrated commercial and bioinformatics company that provides evidence-based, clinically beneficial molecular diagnostic tests and pathology services. Interpace Diagnostics develops and commercializes molecular diagnostic tests that deliver cutting-edge genetic and mutational analysis that help risk-stratify patient samples for thyroid, pancreatic, lung, and other cancers to better inform treatment decisions... Interpace Diagnostics was formed in April, 2014 as a Division of PDI, Inc., (created in 1998 as a public company with over 1,000 employees that provided Contract Sales services to pharmaceutical companies.) After the sale of the pharmaceutical contract sales business in December of 2015, Interpace Diagnostics Group became the sole operating company and the name PDI was changed to Interpace Diagnostics Group, Inc. In July of 2019, the Company acquired the biopharma services division of Cancer..

Also known as: Interpace Biosciences®, Inc., Interpace Diagnostics, Interpace Diagnostics Group, Inc., Interpace Diagnostics®, LLC

Primary location: Parsippany United States